Weight-loss surgery may reduce pancreatic cancer risk in people with obesity

FHS
October 9, 2024
12:42 pm

Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death rate.

Boston Scientific wins diabetic neuropathy approval, joining rivals in growing market

Dive Brief: Boston Scientific has received Food and Drug Administration approval for its spinal cord stimulation device in painful diabetic peripheral neuropathy (PDN). The expanded indication

October 12, 2023

CMS Proposed Rule for CY 2025 Medicare Physician Fee Schedule

– The Centers for Medicare & Medicaid Services (CMS) released a proposed rule outlining changes to Medicare payments under the Physician Fee Schedule (PFS) for

July 15, 2024

Nuvation inks all-stock deal for US-China oncology biotech AnHeart

Nuvation Bio plans to buy AnHeart Therapeutics in an all-stock deal, the cancer drug developers said Monday morning, in a move that could turn Nuvation

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.